在现场形成AIEgen-alginate水凝,用于重塑瘤微环境,以促进FLASH免疫放射治疗
Meng Lyu1, Tianfu Zhang2, Zhirong Bao3
1Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, 518020, China.
Biomaterials
|March 26, 2025
概括
这项研究引入了一种AIEgen-alginate水凝,以增强FLASH放射治疗和光动力学疗法 (PDT) 的结肠癌治疗. 这种新的方法诱导免疫细胞死亡,增强抗瘤免疫力,并防止瘤复发.
科学领域:
- 在瘤学瘤学.
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
背景情况:
- 闪光辐射疗法提供了快速的瘤切除,但由于免疫抑制性瘤微环境 (TME) 导致的瘤细胞杀死不完全面临挑战.
- TME可能会阻碍晚期癌症治疗的疗效,需要制定克服其免疫抑制作用的策略.
研究的目的:
- 开发一种基于水凝的新型系统,使结肠癌对FLASH放射治疗和光动力学疗法 (PDT) 敏感.
- 调查结合聚合诱导排放光原体 (AIEgen) -酸盐水凝与PDT和FLASH放射治疗以增强抗瘤免疫力的潜力.
主要方法:
- 用AIEgen (CQu) 合的花样碳酸纳米颗粒的设计,并与酸盐结合,在酸性TME中形成局部水凝 (FA).
- 使用FA水凝在TME中捕获CQu,然后进行激光照射以诱导持续的活性氧物种 (ROS) 生产.
- 用单次注射FA水凝,然后进行PDT和FLASH放射治疗,以诱导免疫性瘤细胞死亡.
主要成果:
- 开发的水凝系统有效地产生了持续的ROS产量,并诱导了Ca2+过载,导致癌细胞中的线粒体损伤.
- 使用FA水凝,PDT和FLASH放射治疗的联合治疗成功诱导了免疫性瘤细胞死亡.
- 该疗法促进了抗瘤免疫力,防止瘤复发,并显示出了腹效应.
结论:
- 该AIEgen-alginate水凝系统显示出显著的潜力,可以提高FLASH放射治疗和PDT治疗结肠癌的疗效.
- 持续的ROS生产和Ca2+过载是改善瘤细胞对FLASH放射治疗的敏感性和实现最佳免疫治疗结果的关键机制.
- 这种创新方法为克服TME介导的免疫抑制和提高癌症治疗疗效提供了一个有希望的策略.
更多相关视频
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Tumor Immunotherapy
450
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450


